Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Europe symbols : NVAX save search
Novavax Advances Science Supporting Protein-based Vaccine Technology at IDWeek 2023 and World Vaccine Congress Europe 2023
Published: 2023-10-11 (Crawled : 14:00) - biospace.com/
NVAX | $4.12 -3.74% -3.63% 4.7M
|
Health Technology
|
| O: 0.68%
H: 9.29%
C: 2.69%
europe vaccine congress world technology
ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS
Published: 2023-08-08 (Crawled : 14:00) - biospace.com/
ENDPQ 6 d | $0.0018 500.0% -50.0% 360K
|
n/a
|
| O: -10.0%
H: 11.11%
C: 0.0%
NVAX | $4.12 -3.74% -3.63% 4.7M
|
Health Technology
|
| O: 7.98%
H: 8.62%
C: -10.96%
financial results
Novavax to Share New Data from Growing Vaccine Portfolio at World Vaccine Congress Europe 2022
Published: 2022-10-10 (Crawled : 13:00) - biospace.com/
NVAX | $4.12 -3.74% -3.63% 4.7M
|
Health Technology
|
| O: 0.89%
H: 11.22%
C: 8.12%
europe growing vaccine
Novavax Receives Positive European Medicines Agency Recommendation for Conditional Marketing Authorization of its COVID-19 Vaccine
Published: 2021-12-20 (Crawled : 14:30) - biospace.com/
NVAX | $4.12 -3.74% -3.63% 4.7M
|
Health Technology
|
| O: 11.76%
H: 2.83%
C: -12.2%
covid-19 europe covid authorization positive vaccine
Novavax Confirms European Medicines Agency Review of COVID-19 Vaccine Filing for Conditional Marketing Authorization
Published: 2021-11-17 (Crawled : 15:00) - biospace.com/
NVAX | $4.12 -3.74% -3.63% 4.7M
|
Health Technology
|
| O: 2.8%
H: 0.0%
C: 0.0%
covid europe vaccine covid-19
Novavax Files for COVID-19 Vaccine Authorization with Health Canada and Completes Submission for Rolling Review to European Medicines Agency
Published: 2021-11-01 (Crawled : 11:00) - prnewswire.com
NVAX | $4.12 -3.74% -3.63% 4.7M
|
Health Technology
|
| O: 7.21%
H: 8.92%
C: 8.08%
covid europe vaccine submission
Novavax to Participate in World Vaccine Congress Europe
Published: 2021-10-15 (Crawled : 21:00) - biospace.com/
NVAX | $4.12 -3.74% -3.63% 4.7M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
europe vaccine
Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine
Published: 2021-08-04 (Crawled : 14:00) - biospace.com/
NVAX | $4.12 -3.74% -3.63% 4.7M
|
Health Technology
|
| O: 9.33%
H: 12.16%
C: 8.56%
covid europe vaccine
European Vaccines Market 2020-2026 by Type, Disease, Administration, Patient, and Country
Published: 2021-06-10 (Crawled : 19:00) - prnewswire.com
JNJ | $147.59 0.05% -0.18% 6.4M
|
Health Technology
|
| O: -0.01%
H: 0.01%
C: -1.26%
GSK | $40.5 -0.39% -1.09% 2.7M
|
Health Technology
|
| O: 0.05%
H: 0.12%
C: -0.25%
SNY | $46.24 0.68% 0.63% 1.6M
|
Health Technology
|
| O: 0.13%
H: 0.11%
C: -0.09%
NVAX | $4.12 -3.74% -3.63% 4.7M
|
Health Technology
|
| O: -0.21%
H: 3.31%
C: 2.53%
AZN | $68.73 -0.29% -0.26% 7.1M
|
Health Technology
|
| O: 0.49%
H: 0.03%
C: -0.61%
disease europe vaccine
Gainers vs Losers
| 46% | 54% |
Top 10 Gainers
KAVL | $6.3 135.96% 57.45% 44M
|
Wholesale Trade
PXMD | $0.74 79.7% 44.16% 4.5M
|
Health Technology
DYNT | $0.3704 -5.27% 43.09% 1.6M
|
Health Technology
LGVN P 3 d | $2.93 73.37% 42.52% 56M
|
HUBC | $1.95 50.0% 32.99% 73M
|
n/a
SPCB | $0.4004 45.07% 31.75% 130M
|
Electronic Technology
ONVO | $1.35 33.65% 24.62% 53M
|
Health Technology
OMQS | $0.7038 35.35% 24.3% 3.5M
|
Professional, Scientific, and T...
SNPO | $10.54 29.48% 22.88% 3.9M
|
EEIQ | $1.16 27.46% 20.86% 6.9K
|
Educational Services
Your saved searches
Save your searches and get alerts when important news are released.